The LAM Foundation is proud to partner with the UPenn Center for Orphan Diseases for the 9th annual Million Dollar Bike Ride. In the last years' time, The LAM Foundation's Easy Breathers Cycling Team has raised more than $738,500 for LAM research. In 2022, our goal is to raise another $60,000. Join us on June 11, 2022, as we pedal to put an end to lymphangioleiomyomatosis!

We can do this again with your support:
Every dollar we raise up to $30,000, it will be matched by UPenn, doubling the impact!
100% of your donation is tax-deductible.
As a result of our efforts to date, nine well-known LAM researchers received pilot grants to continue critical LAM research including:

- Yan Tang, PhD, from Brigham and Women's Hospital
- Carmen Priolo, MD, PhD from Brigham and Women's Hospital
- Elizabeth Henske, MD from Brigham and Women's Hospital (3x Pilot Grant Award Winner)
- Hilairie Lam, PhD from Brigham and Women's Hospital
- David Kwiatkowski, MD, PhD from Brigham and Women's Hospital (2x Pilot Grant Award Winner)
- Jane Yu, PhD from the University of Cincinnati
- Victoria Stepanova, PhD from the University of Pennsylvania School of Medicine
- Norbert Perrimon, PhD from Harvard Medical School
- Vera Krymskaya, PhD, MBA from the University of Pennsylvania School of Medicine
- Aristotelis Astreinidis, PhD from Texas Tech University Health Sciences Center

For more details regarding LAM research funded by the pilot grants visit https://thelamfoundation.org/Investigators/Other-Programs/UPENN-Orphan-Disease-Program-Grants

LAM is a progressive and rare lung disease that primarily affects women during the prime of their lives. With LAM, a patient's lungs are invaded by mutant smooth muscle cells, which dissolve healthy lung tissue and replace it with innumerable air-filled holes or cysts. Debate is ongoing about the links between LAM and cancer.

LAM is often misdiagnosed, undiagnosed, or under-diagnosed. Early symptoms may resemble asthma, emphysema, or bronchitis.

A LAM diagnosis once meant certain lung failure leading to a lung transplant or death. Now, LAM patients' outlook often centers on the word "hope." In great part, this is due to The LAM Foundation's strategy of "relentless collaboration" with researchers, clinicians, patients, and government health agencies around the world.

The LAM Foundation, based in Cincinnati, OH, has a mission to "urgently seek safe and effective treatments, and ultimately a cure for LAM through advocacy and the funding of promising research."


THANK YOU!
Your support moves research faster toward a cure. Ask your friends and family to join in and help fund-a-cure for LAM! Let's make this the best year ever.

For more information on LAM, please visit us at www.thelamfoundation.org. For fundraising inspiration, check out https://vimeo.com/195956048.